These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6297805)

  • 1. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that lithium ions can modulate lectin stimulation of lymphoid cells by multiple mechanisms.
    Hart DA
    Cell Immunol; 1981 Mar; 58(2):372-84. PubMed ID: 6260387
    [No Abstract]   [Full Text] [Related]  

  • 3. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome.
    Cossarizza A; Monti D; Bersani F; Scarfi MR; Zanotti M; Cadossi R; Franceschi C
    Aging (Milano); 1991 Sep; 3(3):241-6. PubMed ID: 1837237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mitogen lectin on lymphocyte or brain cortex cell activation.
    Kovaru H; Kovaru F; Pav M; Dvorak R; Palikova M; Raboch J; Zidková J
    Neuro Endocrinol Lett; 2010; 31(3):325-9. PubMed ID: 20588247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of prostaglandins on the proliferation of cultured human T lymphocytes.
    Maca RD
    Immunopharmacology; 1983 Dec; 6(4):267-77. PubMed ID: 6317610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte proliferation in Down's syndrome measured by sister chromatid differential staining.
    Crossen PE; Morgan WF
    Hum Genet; 1980; 53(3):311-3. PubMed ID: 6154638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon.
    Gurari-Rotman D; Revel M; Tartakovsky B; Segal S; Hahn T; Handzel Z; Levin S
    FEBS Lett; 1978 Oct; 94(2):187-90. PubMed ID: 151636
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lypmhocyte subpopulations in Down's syndrome. A study on non-institutionalised subjects.
    Franceschi C; Licastro F; Paolucci P; Masi M; Cavicchi S; Zannotti M
    J Ment Defic Res; 1978 Sep; 22(3):179-91. PubMed ID: 151743
    [No Abstract]   [Full Text] [Related]  

  • 12. An apparently immunoregulatory effect of human leukocyte interferon on the blastogenic response in Down's syndrome.
    Hahn T; Levin S; Handzel ZT; Ashkenazi A; Chemke J; Shterk V
    Isr J Med Sci; 1979 Sep; 15(9):775-8. PubMed ID: 159876
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
    Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
    Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical events associated with lymphocyte activation in aging. K+ transport and sensitivity of the Na+-K+ pump to digoxine.
    Kennes BJ; Moest PF; Neve PE
    Exp Gerontol; 1982; 17(4):245-54. PubMed ID: 6297941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.
    Duijndam-van den Berge M; Goekoop JG
    J Neurol Neurosurg Psychiatry; 1986 May; 49(5):595-8. PubMed ID: 2940340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
    Singh VK; Fudenberg HH; Brown FR
    Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological and virological investigations in Down's syndrome.
    Fekete G; Kulcsár G; Dán P; Nász I; Schuler D; Dobos M
    Eur J Pediatr; 1982 Feb; 138(1):59-62. PubMed ID: 6281021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities.
    Rabinowe SL; Rubin IL; George KL; Adri MN; Eisenbarth GS
    J Autoimmun; 1989 Feb; 2(1):25-30. PubMed ID: 2526634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.